NCT06554470View on ClinicalTrials.gov

Local vs Systemic Methotrexate in Management of Uterine Ectopic Pregnancy

NARecruitingINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

August 15, 2024

Primary Completion Date

July 1, 2025

Study Completion Date

July 1, 2025

Conditions
LocalSystemicMethotrexateUterine Ectopic Pregnancy
Interventions
DRUG

Systemic Methotrexate

Patients will receive systemic methotrexate (intramuscular; 50 mg/m2 body weight).

DRUG

Local Methotrexate

Patients will receive local methotrexate (25 mg methotrexate as a fixed dose).

Trial Locations (1)

31527

RECRUITING

Tanta University, Tanta

All Listed Sponsors
lead

Tanta University

OTHER